BRAF and colorectal carcinoma: The mechanism analysis revealed that activated SRC could reprogram the transcriptional activity of β‐catenin through phosphorylation, mediating the downstream gene expression and thus mediating resistance to BRAF inhibitors in BRAFV600E‐mutant CRC.